Literature DB >> 16496674

[Effects of acidic oligose on differentially expressed genes in the mice model of Alzheimer's disease by microarray].

Ling-na Kong1, Mei-yu Geng, Liang Mu, Xian-liang Xin, Nan Yang, Ping-ping Zuo.   

Abstract

AIM: To investigate the molecular mechanism of protective effect of acidic oligose 971 on Alzheimer's disease mouse model by using microarray.
METHODS: Balb/c mice were randomly divided into control group, beta-AP(25-35) i.c.v. injected group and 971-treated group. The learning-memory ability of mice was tested by Morris water maze experiment. Total RNA of the cerebral cortex was extracted from the mice of each group. cDNA microarrays containing 1176 genes were used to investigate the gene expression pattern of each group. Expressions of 5 genes were randomly selected for further confirmation by RT-PCR.
RESULTS: Icv injection of beta-AP(25-35) caused significant impairments in spatial and working memory performances of mice in Morris water maze and which were relieved by the treatment of 971. Up- and down- regulated genes were 19 and 12 in beta-AP(25-35)-injected group vs control group, respectively. Up- and down- regulated genes were 13 and 4, respectively, in 971-treated group vs beta-AP(25-35)-injected group. RT-PCR results indicated that 5 genes showed identical results to that of the microarray.
CONCLUSION: The protective effect of 971 on learning and memory ability of beta-AP(25-35)-treated mouse may be related to the expression changes of genes involved in cell cycle, DNA repair, nerve growth, synaptic plasticity and immune response, etc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16496674

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  5 in total

Review 1.  History and progress of hypotheses and clinical trials for Alzheimer's disease.

Authors:  Pei-Pei Liu; Yi Xie; Xiao-Yan Meng; Jian-Sheng Kang
Journal:  Signal Transduct Target Ther       Date:  2019-08-23

2.  Omission of previous publications by an author should be corrected.

Authors:  Yi Rao
Journal:  Cell Res       Date:  2020-09       Impact factor: 25.617

3.  Geng et al. reply.

Authors:  Xinyi Wang; Guangqiang Sun; Teng Feng; Jing Zhang; Xun Huang; Tao Wang; Zuoquan Xie; Xingkun Chu; Jun Yang; Huan Wang; Shuaishuai Chang; Yanxue Gong; Lingfei Ruan; Guanqun Zhang; Siyuan Yan; Wen Lian; Chen Du; Dabing Yang; Qingli Zhang; Feifei Lin; Jia Liu; Haiyan Zhang; Changrong Ge; Shifu Xiao; Jian Ding; Meiyu Geng
Journal:  Cell Res       Date:  2020-09       Impact factor: 25.617

4.  A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia.

Authors:  Shifu Xiao; Piu Chan; Tao Wang; Zhen Hong; Shuzhen Wang; Weihong Kuang; Jincai He; Xiaoping Pan; Yuying Zhou; Yong Ji; Luning Wang; Yan Cheng; Ying Peng; Qinyong Ye; Xiaoping Wang; Yuncheng Wu; Qiumin Qu; Shengdi Chen; Shuhua Li; Wei Chen; Jun Xu; Dantao Peng; Zhongxin Zhao; Yansheng Li; Junjian Zhang; Yifeng Du; Weixian Chen; Dongsheng Fan; Yong Yan; Xiaowei Liu; Wei Zhang; Benyan Luo; Wenyuan Wu; Lu Shen; Chunfeng Liu; Peixian Mao; Qiumei Wang; Qianhua Zhao; Qihao Guo; Yongtao Zhou; Yi Li; Lijun Jiang; Wenwei Ren; Yingjun Ouyang; Yan Wang; Shuai Liu; Jianjun Jia; Nan Zhang; Zhonglin Liu; Raoli He; Tingyi Feng; Wenhui Lu; Huidong Tang; Ping Gao; Yingchun Zhang; Lanlan Chen; Lei Wang; You Yin; Qun Xu; Jinsong Xiao; Lin Cong; Xi Cheng; Hui Zhang; Dan Gao; Minghua Xia; Tenghong Lian; Guoping Peng; Xu Zhang; Bin Jiao; Hua Hu; Xueyan Chen; Yihui Guan; Ruixue Cui; Qiu Huang; Xianliang Xin; Hongjian Chen; Yu Ding; Jing Zhang; Teng Feng; Marc Cantillon; Kewei Chen; Jeffrey L Cummings; Jian Ding; Meiyu Geng; Zhenxin Zhang
Journal:  Alzheimers Res Ther       Date:  2021-03-17       Impact factor: 6.982

5.  A phase II randomized trial of sodium oligomannate in Alzheimer's dementia.

Authors:  Tao Wang; Weihong Kuang; Wei Chen; Wenwei Xu; Liming Zhang; Yingjie Li; Hailin Li; Ying Peng; Yangmei Chen; Baojun Wang; Jinsong Xiao; Honghua Li; Chuanzhu Yan; Yifeng Du; Mouni Tang; Zhiyi He; Haibo Chen; Wei Li; Hong Lin; Shugui Shi; Jianzhong Bi; Huadong Zhou; Yan Cheng; Xiaoping Gao; Yihui Guan; Qiu Huang; Kewei Chen; Xianliang Xin; Jian Ding; Meiyu Geng; Shifu Xiao
Journal:  Alzheimers Res Ther       Date:  2020-09-14       Impact factor: 6.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.